Ladenburg Thalmann & Co. Inc. Issues Positive Forecast for Paysign (NASDAQ:PAYS) Stock Price

Paysign (NASDAQ:PAYS) had its target price increased by Ladenburg Thalmann & Co. Inc. from $14.00 to $15.25 in a research note published on Wednesday,Benzinga reports. The brokerage currently has a buy rating on the stock.

PAYS has been the subject of a number of other reports. Maxim Group downgraded shares of Paysign from a “buy” rating to a “hold” rating in a report on Wednesday. Weiss Ratings raised shares of Paysign from a “buy (b-)” rating to a “buy (b)” rating in a research note on Thursday, October 8th. DA Davidson decreased their target price on shares of Paysign from $15.00 to $14.00 and set a “buy” rating on the stock in a research report on Wednesday. Wall Street Zen lowered shares of Paysign from a “strong-buy” rating to a “buy” rating in a research report on Sunday, August 16th. Finally, Barrington Research set a $15.00 target price on shares of Paysign in a research note on Tuesday, August 11th. Four research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $14.81.

Paysign Price Performance

Shares of NASDAQ PAYS opened at $9.48 on Wednesday. Paysign has a 12-month low of $3.08 and a 12-month high of $16.15. The company has a market capitalization of $535.24 million, a PE ratio of 30.73 and a beta of 0.92. The firm’s 50-day moving average is $13.76 and its two-hundred day moving average is $8.66.

Paysign (NASDAQ:PAYS) last issued its quarterly earnings data on Monday, November 9th. The company reported $0.11 earnings per share for the quarter, topping analysts’ consensus estimates of $0.09 by $0.02. Paysign had a net margin of 18.48% and a return on equity of 37.20%. The business had revenue of $30.80 million during the quarter, compared to analysts’ expectations of $29.02 million. On average, analysts forecast that Paysign will post 0.38 EPS for the current fiscal year.

Insider Buying and Selling

In other Paysign news, insider Michael C. Ngo sold 79,925 shares of Paysign stock in a transaction dated Wednesday, September 9th. The stock was sold at an average price of $12.74, for a total value of $1,018,244.50. Following the completion of the sale, the insider owned 2,350,000 shares in the company, valued at $29,939,000. The trade was a 3.29% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Joan M. Herman sold 38,900 shares of the company’s stock in a transaction dated Wednesday, September 16th. The shares were sold at an average price of $11.74, for a total transaction of $456,686.00. Following the transaction, the executive vice president directly owned 609,421 shares of the company’s stock, valued at approximately $7,154,602.54. This represents a 6.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 259,904 shares of company stock worth $3,402,424. 24.50% of the stock is owned by company insiders.

Institutional Trading of Paysign

A number of institutional investors and hedge funds have recently bought and sold shares of the business. HighTower Advisors LLC purchased a new position in Paysign in the third quarter valued at about $297,000. Virtus Advisers LLC purchased a new stake in shares of Paysign in the third quarter worth about $282,000. Diversified Trust Co purchased a new stake in shares of Paysign in the third quarter worth about $234,000. Russell Investments Group Ltd. grew its stake in shares of Paysign by 171.1% in the third quarter. Russell Investments Group Ltd. now owns 156,825 shares of the company’s stock valued at $2,114,000 after buying an additional 98,980 shares in the last quarter. Finally, Lisanti Capital Growth LLC acquired a new stake in shares of Paysign in the third quarter valued at about $839,000. Institutional investors and hedge funds own 25.89% of the company’s stock.

Latest Paysign News

Investors following PAYS have been watching these news items:

• Neutral Sentiment: DA Davidson lowered its target to $14 from $15 but maintained a Buy rating, suggesting its outlook remains positive despite a reduced valuation estimate. DA Davidson ratings
• Neutral Sentiment: Trading in Paysign call options surged to 2,581 contracts, about 712% above the average. This may indicate increased bullish positioning, though options activity alone does not establish the outlook for the shares.
• Negative Sentiment: The company’s 2026 adjusted EPS guidance of $0.37–$0.38 is below the $0.51 analyst consensus. Revenue guidance of $114 million–$117 million is broadly around consensus, but a customer’s pullback raised concerns about future revenue. These outlook concerns appear to be the main source of pressure on the stock. Paysign Falls as Customer’s Pullback Weighs on Future Revenue

About Paysign

Paysign, Inc. provides prepaid card programs, payment processing and related financial technology services. Its platform supports organizations that need to distribute funds and manage payments, including businesses in the healthcare sector. The company serves plasma collection centers with donor compensation and payment solutions, and works with pharmaceutical companies on patient assistance and affordability programs. Its services also support payments for clinical trials and other disbursement needs.